Acute inflammation alters bicarbonate transport in mouse ileum

Hui Zhang1, Nadia Ameen, James E Melvin

  • 1Digestive Diseases, Department of Medicine, Center for Oral Biology, University of Rochester School of Medicine, 601 Elmwood Ave, Box 646, Rochester, NY 14642, USA.

Insights

Acute ileal inflammation in Crohn's disease involves altered bicarbonate secretion. This study reveals that T-cell activation shifts secretion towards cystic fibrosis transmembrane conductance regulator (CFTR)-mediated pathways, impacting fluid balance.

Area of Science:

  • Gastroenterology
  • Physiology
  • Immunology

Background:

  • Crohn's disease exacerbations involve T-cell mediated ileal inflammation.
  • Inflammation decreases nutrient absorption and increases fluid secretion, causing diarrhea.
  • Mechanisms of ileal bicarbonate secretion during inflammation are poorly understood.

Purpose of the Study:

  • To investigate the regulation and mechanisms of bicarbonate (HCO3-) secretion in normal and inflamed ileum.
  • To elucidate the role of cystic fibrosis transmembrane conductance regulator (CFTR) in ileal inflammation.

Main Methods:

  • Utilized anti-CD3 monoclonal antibody (mAb) induced ileal inflammation in mouse models.
  • Employed Ussing chamber and pH stat techniques for in vitro functional studies.
  • Analyzed protein levels via Western blot and intracellular cAMP via immunoassay.

Main Results:

  • Anti-CD3 mAb induced a significant increase in ileal short circuit current (Isc), mediated by CFTR.
  • Basal chloride-dependent HCO3- secretion decreased, while chloride-independent HCO3- secretion increased and was inhibited by glibenclamide.
  • CFTR knockout mice showed no increase in Isc or HCO3- secretion, confirming CFTR's role.
  • Intracellular cAMP levels increased in villus cells but not crypt cells.

Conclusions:

  • Acute ileal inflammation shifts bicarbonate secretion from electroneutral exchange to electrogenic anion secretion via functional CFTR.
  • CFTR plays a critical role in mediating increased anion secretion during T-cell-induced ileal inflammation.
  • These findings provide insights into fluid dysregulation during Crohn's disease flares.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...